CRL

查尔斯河实验室
NYSE

实时行情|Nasdaq Last Sale

221.60
+3.80
+1.74%
盘后: 221.60 0 0.00% 16:00 08/07 EDT
开盘
217.30
昨收
217.80
最高
221.64
最低
215.71
成交量
50.40万
成交额
--
52周最高
220.01
52周最低
95.58
市值
109.66亿
市盈率(TTM)
40.79
分时
5日
1月
3月
1年
5年

分析师评级

18位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CRL价格均价为228.44,最高价位256.00,最低价为186.00。

EPS

CRL 新闻

更多
World's First Development and Demonstration of a Quantum Cryptographic Communication Technology Applied System for Genomic Medicine
Toshiba Corporation (TOKYO: 6502), Tohoku University Tohoku Medical Megabank Organization (ToMMo) and Tohoku University Hospital have demonstrated that quantum cryptographic communications technology can provide genomic medicine with a safe, completely secure
PR Newswire · 1天前
Charles River Laboratories International Inc (CRL) Q2 2020 Earnings Call Transcript
CRL earnings call for the period ending June 30, 2020.
Motley Fool · 2天前
Charles River Laboratories (CRL) Q2 Earnings and Revenues Beat Estimates
Charles River (CRL) delivered earnings and revenue surprises of 24.41% and 7.41%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 2天前
Charles River Laboratories Raises FY20 Adj. EPS Guidance From $6.75–$7.10 To $7.05–$7.35 vs $6.91 Est.
Benzinga · 3天前
Charles River Q2 Adj. EPS $1.58 Beats $1.26 Estimate, Sales $682.58M Beat $641.63M Estimate
Charles River (NYSE:CRL) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.26 by 25.4 percent. This is a 3.07 percent decrease over earnings of $1.63 per share from the same
Benzinga · 3天前
Charles River Q2 Adj. EPS $1.58 Beats $1.26 Estimate, Sales $682.58M Beat $641.63M Estimate
Charles River (NYSE:CRL) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.26 by 25.4 percent. This is a 3.07 percent decrease over earnings of $1.63 per share from the same
Benzinga · 3天前
Charles River Laboratories Announces Second-Quarter 2020 Results
Charles River Laboratories Announces Second-Quarter 2020 Results
Business Wire · 3天前
Agilent Technologies At Upper End Of Buy Range With Earnings Due
To build your earnings season watch list, look for stocks in or near a potential buy range ahead of their next report. One company that fits that bill is Agilent Technologies (A). It's expected to report on Aug. 18. The stock is approximately 5% above a 93.14
Investor's Business Daily · 3天前

所属板块

生物技术和医学研究
-0.18%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

CRL 简况

Charles River Laboratories International, Inc.是一家提供全套服务的初期合约研究公司。该公司提供新药、设备及疗法的研发所需的研究模型。该公司通过三大部门运营。研究模型及服务部门包括研究模型业务及研究模型服务业务。探索及安全评估部门提供管制及非管制的探索及安全评估服务,包括体内研究及体外研究。制造支持部门包括微生物解决方案业务、生物制剂测试解决方案业务以及禽流感疫苗服务业务。该公司开发多种探索及安全评估服务,包括药品非临床研究质量管理规范(GLP)服务及非GLP服务。该服务为客户提供从目标识别到临床前开发阶段的帮助。
展开

微牛提供Charles River Laboratories Intl. Inc(NYSE-CRL)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CRL股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CRL股票基本功能。